David joined Arch Venture Partners in 2007. He focuses on instrumentation, biotechnology, medical diagnostics and devices, nanotechnology, semiconductors and information technologies and has supported the formation, investment, and growth of a number of companies including Twist Bioscience (TWST) and 908 Devices (MASS).
He holds an M.B.A with Honors from the University of Chicago, a M.S. in Industrial Engineering and Operations Research from the University of California, Berkeley, and a B.S. in Mechanical Engineering from the University of California, Los Angeles, where he graduated Summa Cum Laude and was elected to Phi Beta Kappa.